SUPPLEMENTARY METHODS
Animals C57BL/6J (Ly5.2) and B6.SJL-Ptprc a Pepc b /BoyJ (Ly5.1) mice were used in this study. Breeding of Ly5.1 mice was performed in homozygosity in our local animal facility (UKE, Hamburg, Germany) and C57BL/6J (Ly5.2) mice were purchased from Charles River Laboratories (Sulzfeld, Germany) . Experiments were performed with 4-8 week old female mice as indicated. All experiments were carried out in concordance with the institutional guidelines for the welfare of animals and were approved by the local licensing authority (Behörde für Soziales, Gesundheit, Familie, Verbraucherschutz; Amt für Gesundheit und Verbraucherschutz, Hamburg, Germany, project number G128/16).
Treatments and mixed bone marrow chimeras
For HSC transplantation experiments, Ly5.1 animals received daily i.p injections with 50 mg/kg JQ1 or placebo for 21 days. The BET-inhibitor JQ1 was synthesized and supplied by Prof. Dr. Stefan Knapp and Marek Wanior (Goethe University Frankfurt am Main). To increase aqueous solubility, injection solutions were prepared by diluting DMSO stock solutions dropwise 1:10 in 10 % (2-Hydroxypropyl)-βcyclodextrin. At day of sacrifice, different cell numbers from bone marrow or spleen of pretreated animals (2x10 3 , 2x10 4 or 2x10 5 ) were mixed with 2x10 5 untreated Ly5.2 supporter BM cells and injected i.v. into lethally irradiated Ly5.2 mice (2x 4,5 Gy split dose at an interval of 4 hours). For secondary transplantation experiments, 4 x 10 6 BM cells from animals originally transplanted with 2 x 10 5 JQ1-or placebo-treated Ly5.1 bone marrow cells were injected i.v. into lethally irradiated Ly5.2 mice (2x 4,5
Gy split dose at an interval of 4 hours). After each transplantation engraftment was monitored in PB (Hemavet 950, ERBA diagnostics Mannheim GmbH, Mannheim, Germany) and BM at indicated time points.
Transplantation experiments were performed with total numbers of BM cells per condition and not corrected for equal numbers of HSC.
We therefore normalized the measured CD45.1 + chimerism in the peripheral blood of the secondary recipients to the chimerism of the donor animals (primary recipients).
Thereby we corrected for different ratios of transplanted cells (CD45.1 vs. CD45.2) at the time point of secondary transplantation.
In this context, "100 % CD45.1 (% donor CD45.1)" means that secondary recipients harbor the same amount of CD45.1+ cells in peripheral blood as their respective donor animal before secondary transplantation (e.g. primary and secondary recipients both have/had 65 % CD45.1 + cells in peripheral blood). For comparison, the raw data without normalization can be found in the supplementary data ( Supplementary Figure 4) .
The calculation of repopulating units (RU) was performed with lethally irradiated Ly5.2 mice transplanted with 2x10 5 BM cells from placebo or JQ1 treated Ly5.1 mice together with 2x10 5 supporter BM cells from untreated Ly5.2 mice. RU values are calculated from percentages of donor-derived lymphocytes in the primary recipients 4 months after transplantation using the following formula: RU donor = RU competitor x (% lymphocytes donor / 100 -% lymphocytes donor )
The relative repopulating abilities of 100,000 competitor marrow cells is defined as one RU.
Colony formation assays
Colony formation assays for the quantification of hematopoietic stem and progenitor cells or megakaryocytes were performed using fully supplemented MethoCult GF M3434, H4034 Optimum or MegaCult-C (Stemcell Technologies, Vancouver, Canada), respectively, according to manufacturer's instructions. Colonies (defined as >100 cells) were scored 7 (M3434 and MegaCult-C) or 14 (H4034 Optimum) days after plating of cells. For serial replating assays, cells were replated and scored every 7 days for four rounds.
ELISA and RT-qPCR
Transcript levels were analyzed using Power SYBR Green RT-qPCR (Applied Biosystems, Foster City, CA, USA) and protein concentrations were determined using ELISA according to manufacturer's instruction (R&D Systems, Minneapolis, MN, USA). All Oligonucleotides that were used for analyzes are listed below.
Oligonuceotides for qRT-PCR

Gene
Primer name Oligonucleotide sequences
Brd4_fwd Brd4_rev 5´-GGA ATT TGG TGC TGA TGT CCG-3´ 5´-GTG GGG CTA CCA CCT TTG TA -3´ 
